 | • レポートコード：D0-MOR-AP1184 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、尿失禁治療の世界市場について調査・分析した資料で、尿失禁治療の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Urinary Incontinence Treatment Devices market is projected to grow with a CAGR of 7.6% over the forecast period. The major factor attributing to the growth of the market is the rising prevalence of urinary incontinence. Numerous factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence symptoms. According to the Gothenburg Continence Research Center, in 2018 more than 423 million people suffered from urinary incontinence of which, 303 million were women. Furthermore, rising demand for minimally invasive procedures and increasing technological advancements boost the market growth. However, a lack of skilled professionals is the major drawback of market growth.
Key Market Trends
Urethral Slings Dominate the Urinary Incontinence Treatment Devices Market
Urethral slings are the procedure that is highly recommended for surgical treatment for treating stress urinary incontinence. The urethral sling is considered as the gold standard method that has replaced all conventional procedures such as colposuspension and vaginal mesh. The dominant share of the segment can be attributed to the large sales of the vaginal slings.
The growing volume of urinary incontinence and cumulative research in the arena of urinary incontinence treatment adoptions are the major factors for the growth of the segment. Moreover, the aging population is boosting segment growth.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall urinary incontinence treatment devices market, throughout the forecast period. The largest share is mainly due to the presence of a larger patient pool and increasing geriatric population. Furthermore, well-established insurance policies and the availability of advanced healthcare infrastructure are a few of the other factors boosting the market in this region. In the North America region, the United States holds the largest market share due to factors such as the increasing number of geriatric populations, along with a growing number of patient pools in the country. According to the National Association for Incontinence, more than 25 million people in the United States experience bladder leakage every day. As per the statistics the large patient pool and high disposable income propels the market growth in the region.
Competitive Landscape
The Urinary Incontinence Treatment Devices market is moderately competitive. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Becton, Dickinson and Company., Coloplast Corp, Promedon Group, A.M.I. GmbH, Johnson & Johnson, ZSI Surgical Implants S.R.L.,Medtronic plc, Teleflex Incorporated, Hollister Incorporated
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Urinary Incontinence and Rise in Geriatric Population
4.2.2 Rise in Demand for Minimally Invasive Surgery and Product Development
4.3 Market Restraints
4.3.1 Lack of Awareness of the Devices
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Urethral Slings
5.1.2 Electrical Stimulation Devices
5.1.3 Artificial Urinary Sphincters
5.1.4 Catheters
5.2 By End-User
5.2.1 Hospitals
5.2.2 Ambulatory Surgery Centers
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Becton, Dickinson and Company
6.1.3 Coloplast Corp
6.1.4 Promedon Group
6.1.5 A.M.I. GmbH
6.1.6 Johnson & Johnson
6.1.7 ZSI Surgical Implants S.R.L.
6.1.8 Medtronic plc
6.1.9 Teleflex Incorporated
6.1.10 Hollister Incorporated
7 MARKET OPPORTUNITIES AND FUTURE TRENDS